Beyond Air Reports Financial Results for the Quarter Ended September 30, 2026

Beyond Air, Inc. reported revenue of $2.3 million for the quarter ended September 30, 2026, representing approximately 28% year-over-year growth driven by the adoption of its first-generation LungFit PH system. The company recorded a net loss of $7.8 million for the period, compared to a net loss of $7.9 million in the same quarter of the previous year. Management reaffirmed its revenue guidance of $8 million for calendar year 2026 and $16—$18 million for calendar year 2027, the latter of which includes anticipated revenue from the second-generation LungFit PH system pending FDA approval. The company also provided a corporate update, noting that its PMA supplement for the second-generation system remains under FDA review and that it has received Breakthrough Device Designation for its LungFit GO system for NTM-PD, though development resources are currently prioritized toward the secon...